Literature DB >> 11162760

Compliance with health regimens of adolescents with epilepsy.

H Kyngäs1.   

Abstract

The purpose of this paper was to describe the compliance of adolescents with epilepsy and some factors connected to it. Altogether 300 individuals with epilepsy aged 13-17 years were randomly selected from the Finnish Social Insurance Institution's register. Every fifth person on the list was included in the sample. Seventy-seven per cent (n= 232) of the selected adolescents with epilepsy returned a questionnaire sent to them relating to compliance. The data were analysed using the SPSS software. Twenty-two per cent of the adolescents with epilepsy felt that they complied fully with their suggested health regimens, while 44% placed themselves in the category of "satisfactory compliance", and the remaining 34% reported poor compliance. Compliance with their recommended life-style was poorest, while the highest degree of compliance was recorded for medication. Background variables, such as the duration of the disease, exercise, smoking, alcohol-intake and the number of seizures, were statistically significantly related to compliance (P< 0.001). Good motivation, a strong sense of normality, experience of results, subjective outcome, energy and will-power, support from parents, physicians and nurses, and a positive attitude towards to the disease and its treatment, no threat to social and emotional well-being and no fears of complications and no fear of seizures explained good compliance (P< 0.001). Copyright 2000 BEA Trading Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11162760     DOI: 10.1053/seiz.2000.0470

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  19 in total

1.  Correlation between Serum Level of Antiepileptic Drugs and their Side Effects.

Authors:  Abbashar Hussein; Amira Abdulgalil; Faroug Omer; Hassan Eltoum; Ahmed Hamad; Omer El-Adil; Bedraldin Mubarak; Mohmad Malkaldar; Iway Idris; Yasin Alwidaa; Esam Mahmoud
Journal:  Oman Med J       Date:  2010-01

2.  Adherence to medication among outpatient adolescents with epilepsy.

Authors:  Wael M Gabr; Mohamed E E Shams
Journal:  Saudi Pharm J       Date:  2014-05-26       Impact factor: 4.330

3.  Adherence barriers in pediatric epilepsy: From toddlers to young adults.

Authors:  Ana M Gutierrez-Colina; Aimee W Smith; Constance A Mara; Avani C Modi
Journal:  Epilepsy Behav       Date:  2018-02-09       Impact factor: 2.937

4.  White coat adherence over the first year of therapy in pediatric epilepsy.

Authors:  Avani C Modi; Lisa M Ingerski; Joseph R Rausch; Tracy A Glauser; Dennis Drotar
Journal:  J Pediatr       Date:  2012-05-18       Impact factor: 4.406

5.  Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy.

Authors:  Avani C Modi; Shanna M Guilfoyle; Diego A Morita; Tracy A Glauser
Journal:  Epilepsia       Date:  2010-11-18       Impact factor: 5.864

6.  Behavioral predictors of medication adherence trajectories among youth with newly diagnosed epilepsy.

Authors:  Kristin Loiselle; Joseph R Rausch; Avani C Modi
Journal:  Epilepsy Behav       Date:  2015-07-25       Impact factor: 2.937

7.  Treatment adherence among adolescents with epilepsy: what really matters?

Authors:  Loretta Carbone; Bradley Zebrack; Melissa Plegue; Sucheta Joshi; Renée Shellhaas
Journal:  Epilepsy Behav       Date:  2013-01-31       Impact factor: 2.937

Review 8.  [Compliance with antiepileptic drugs].

Authors:  U Specht
Journal:  Nervenarzt       Date:  2008-06       Impact factor: 1.214

9.  An evaluation of factors affecting adherence to antiepileptic drugs in patients with epilepsy: a cross-sectional study.

Authors:  Ranjana Gurumurthy; Kulkarni Chanda; Grk Sarma
Journal:  Singapore Med J       Date:  2016-01-25       Impact factor: 1.858

10.  Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy.

Authors:  Z S Daniels; T G Nick; C Liu; A Cassedy; T A Glauser
Journal:  Neurology       Date:  2009-05-27       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.